Classificazioni citologiche: verso uno schema internazionale unificato?



Similar documents
The Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers.

MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE ASPIRATES OF THE THYROID EFFECTIVE DATE: 11/19/15

Conflict of Interest. Overdiagnosis. Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates 4/17/2015. Jeffrey F.

Guidance on the reporting of thyroid cytology specimens

Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach

Writing Group for the AACE Thyroid Scientific Committee. Bernet V, Hupart KH, Parangi S and Woeber KA

Molecular Diagnostics in Thyroid Cancer

Classifying Your Thyroid FNA Specimens Using Bethesda Terminology: Use of Adjunct Molecular Reflex Testing

BRAF in the diagnostic evaluation of thyroid nodules

Thyroid Cancer Diagnosis and Management. Jerome Hershman, M.D. Internal Medicine Grand Rounds University of Missouri, Columbia October 21, 2010

Frozen Section Diagnosis

Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid

Molecular Markers in Fine Needle Aspirates of the Thyroid

Name of Policy: Molecular Markers in Fine Needle Aspirates of the Thyroid

Thyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules)

GENETICS AND GENOMICS OF THYROID NEOPLASMS MOVING CLOSER TOWARDS PERSONALIZED PATIENT CARE

Molecular Pathogenesis of Thyroid Cancer

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

Cystic Neoplasms of the Pancreas: A multidisciplinary approach to the prevention and early detection of invasive pancreatic cancer.

AACE/AME/ETA Guidelines

THYROID CANCER. I. Introduction

Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare

ATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA

Advances in Differentiated Thyroid Cancer

<1 cm WDT-UMP, FT-UMP. Kakudo K et al, Pathol Int,2009, Endocr J, 2011 and Pathol Int, 2012

Nicole Kounalakis, MD

D. N. Poller and S. Glaysher

Thyroid Cancer: Resection, Dissection, Surveillance and Recurrence. Cord Sturgeon, MD

Thyroid FNA Ancillary Studies. Douglas P. Clark, M.D. Zubair W. Baloch, M.D., Ph.D.

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

Error Reduction and Prevention in Surgical Pathology. Raouf E. Nakhleh, MD Professor of Pathology Mayo Clinic Florida

YOUR LUNG CANCER PATHOLOGY REPORT

Breast Fine Needle Aspiration Cytology Reporting : A Study of Application of Probabilistic Approach

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

Update on thyroid cancer surveillance and management of recurrent disease. Minimally invasive thyroid surgery

Evaluation and Management of the Breast Mass. Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003

Evaluation of the Thyroid Nodule

Explanation of your PAP smear

SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD

Kevin H. Hsu, MS, DO, Corrado Minimo MD, Seth Zwillenberg, MD

Contents. 1. Introduction and Approach to Fine Needle Aspiration Cytology Head, Neck, Orbit and Salivary Glands... 12

The Diagnosis of Cancer in the Pathology Laboratory

Diagnosis of Mesothelioma Pitfalls and Practical Information

Polyps. Hyperplasias. CAP 2011: Course AP104. The High Risk Benign Endometrium. Mutter and Nucci 1

Something Old, Something New.

Molecular pathology of thyroid cancers

Locoregional recurrence or persistence of papillary carcinoma: radioiodine treatment

Update on Mesothelioma

ENDOCRINE PATHOLOGY. Histological Evaluation of Thyroid Lesions by a Scanning Acoustic Microscope

Thyroid Cancer A Multidisciplinary Approach

Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Information Model Requirements of Post-Coordinated SNOMED CT Expressions for Structured Pathology Reports

IV Molecular Cytopathology Focus on Next Generation Sequencing in Cytopathology

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Neoplasms of the LUNG and PLEURA

Surgical Perspective of T1799A BRAF Mutation Diagnostic Value in Papillary Thyroid Carcinoma

OBJECTIVES By the end of this segment, the community participant will be able to:

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet

Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.

Cervical Cancer The Importance of Cervical Screening and Vaccination

Renal Tumors with Eosinophilic Cytoplasm: 2013 Classification. Jesse K. McKenney, MD Associate Head, Surgical Pathology

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer

PREDICTIVE MODEL BASED ON NEURAL NETWORKS TO ASSIST THE DIAGNOSIS OF MALIGNANCY OF THYROID NODULES

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

DIAGNOSTIC USE OF MOLECULAR MARKERS IN THE EVALUATION OF THYROID NODULES

Us TOO University Presents: Understanding Diagnostic Testing

9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH

CHAPTER 2. Neoplasms (C00-D49) March MVP Health Care, Inc.

Surgical guidelines for the management of breast cancer

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.

Cytology of Lymph Nodes

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD

Breast Ultrasound: Benign vs. Malignant Lesions

Office Visits. Breast

Standardized interpretation of fine-needle aspiration

Diagnostic Challenge. Department of Pathology,

GENE EXPRESSION TESTS

Pap smears, cytology and CCHC lab work and follow up

Hepatocellular Carcinoma: What the hepatologist wants to know

Metastatic carcinoma to the thyroid gland from renal cell carcinoma: role of ultrasonography in preoperative diagnosis

Benign Liver Tumors. Cameron Schlegel PGY-1 3/6/2013

Thyroid Carcinoma. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version NCCN.org. Continue

Patologia neoplastica borderline della mammella"

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER

Transcription:

Cytology and molecular biology for thyroid nodules diagnos6c categories to clinical ac6ons From Classificazioni citologiche: verso uno schema internazionale unificato? A. Crescenzi

Diagnostic categories AACE-AME (2006) ATA (2006) PSC (2007) Non diagnostic Benign Suspicious/indeterminate Malignant Unsatisfactory Benign Cellular lesion, can not rule out follicular neoplasm Follicular Neoplasm Suspicious Malignant

Categorie Diagnostiche SIAPEC-SIE (2007) Tir 1. Non diagnostico Tir 2. Negativo per cellule maligne Tir 3. Indeterminato (Proliferazione follicolare) Tir 4. Sospetto per malignità Tir 5. Positivo per cellule maligne BTA (2002/7) Thy 1. Non diagnostic Thy 2. Non neoplastic Thy 3. Follicular lesion Thy 4. Suspicious of malignancy Thy 5. Diagnostic of malignancy

TIR3: Inconclusive/indeterminated (follicular proliferation) Siapec 2007 Adenomatoid hyperplasia Follicular adenoma Follicular carcinoma Hurthle cell neoplasm Follicular variant of papillary carcinoma Worrisome follicular alterations that cannot be placed in Tir2 but are not sufficient for a Tir4 categorization.

Follicular proliferation Needle diameter 300 microns normal follicles 50-500 macrofollicles > 500 microfollicles 10-20 Microfollicles: Crowded, flat groups of less then 15 follicular cells arranged in circle that is at least two thirds complete Renshaw AA et al. Arch Pathol Lab Med 2006: 130: 148

Follicular lesion TIR3 Adenomatoid hyperplasia Follicular neoplasm FNA

Follicular lesion TIR3 Follicular carcinoma: the diagnosis of malignancy depends primarily on the demonstration of unequivocal capsular and/or vascular invasion. FNA

Follicular lesion TIR3 (Follicular variant of papillary carcinoma)

Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules Hossein Gharib, Enrico Papini, Ralf Paschke, Daniel S. Duick, Roberto Valcavi, Laszlo Hegedus, Paolo Vitti, and the AACE /AME/ETA Task Force on Thyroid Nodules. 2010 Cytologic diagnoses should be organized into 5 classes: Class 1. Nondiagnostic (inadequate or insufficient): samples with processing errors or an insufficient number of follicular cells Class 2. Benign (or negative for malignancy): includes colloid or hyperplastic nodules, Hashimoto or granulomatous thyroiditis, and cysts Class 3. Follicular lesions: all follicular-patterned lesions, including follicular neoplasms, Hürthle cell lesions, and the follicular variant of PTC. In centers with specific experience in thyroid cytology, follicular cytology may be further subdivided into follicular lesion/atypia of undetermined significance and follicular neoplasm. This distinction separates 2 cytologic groups at different risk for thyroid malignancy but with the same operative Indications. Class 4. Suspicious: samples that suggest a malignant lesion but do not completely fulfill the criteria for a definite diagnosis Class 5. Malignant (or positive): samples characterized by malignant cytologic features that are reliably identified by the cytopathologist and are diagnostic of primary or metastatic tumors

AACE /AME/ETA J Endocrinol Invest. 33 (Suppl. To no 5): 1 50, 2010 7.3. Follicular Lesions Treatment Surgical excision is recommended for most follicular thyroid lesions Intraoperative frozen section is not recommended as a routine procedure Consider clinical follow-up in the minority of cases with favorable clinical, US, cytologic, and immunocytochemical features

Diagnos(c categories Unsatisfactory Benign Atypia of undetermined significance or follicular lesion of undetermined significance Follicular Neoplasm Suspicious for malignancy Malignant Am J Clin Pathol 2009;132:658-665

The hallmark of this diagnostic category is a disturbed cytoarchitecture: follicular cells are arranged predominantly in microfollicular or trabecular arrangements Benign follicular nodules often have a small population of microfollicles and crowded groups. If these constitute the minority of the follicular cells, they have little significance and the FNA can be interpreted as benign. A suspicious interpretation is rendered only when the majority of the follicular cells are arranged in abnormal architectural groupings (microfollicles, crowded trabeculae).

BETHESDA System Diagnostic Cytopathology, 2008

UK RCPath Diagnostic category Thy1/Thy1c Non-diagnostic for cytological diagnosis Unsatisfactory, consistent with cyst Thy2/Thy2c Non-neoplastic Thy 3a Neoplasm possible atypia/non-diagnostic Thy 3f Neoplasm possible - suggesting follicular neoplasm Thy 4 Suspicious of malignancy Thy5 Malignant

Gabrijela Kocjan et al.

2013 Italian Consensus TIR 3: Indeterminate TIR 3A Cellular microfollicular/hurthle cell pattern in a background of sparse colloid amount with degenerative/regressive features Partially compromised specimens (blood contamination) with mild cytologic or architectural alterations Expected lower risk of malignancy TIR 3B Monotonous, repetitive microfollicular pattern with scanty or absent colloid ( follicular proliferation ) More likely follicular neoplasm; expected higher risk of neoplasia.

UK RCPath SIAPEC-AIT 2013 USA BETHESDA Diagnostic category Terminology Thy1/Thy1c Non-diagnostic for cytological diagnosis Unsatisfactory, consistent with cyst Thy2/Thy2c Non-neoplastic Thy 3a Neoplasm possible atypia/nondiagnostic TIR 1 TIR 1c (cystic) TIR 2 TIR 3A I. Non-diagnostic Cystic fluid only II. Benign III. Atypia of undetermined significance or follicular lesion u.s. AUS/FLUS Thy 3f Neoplasm possible - suggesting follicular neoplasm Thy 4 Suspicious of malignancy TIR 3B TIR 4 IV. Follicular neoplasm or suspicious for a follicular neoplasm V. Suspicious of malignancy Thy5 Malignant TIR 5 VI. Malignant

Am J Clin Pathol 2011;136:896-902

CONSERVATIVE SURGERY RISK VERY LOW LOW INTERMEDIATE HIGH VERY HIGH ACTION CLASS TIR 2 Thy2 Benign Control TIR 3a Thy3a AUS FLUS Repeat FNA TIR 3b Thy3f FN Surgery/ rigoruos follow up TIR 4 Thy4 Suspicious Surgery with intraoperative biopsy TIR 5 Thy5 Malignant Surgery, total resection